Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized Phase II, placebo-controlled trial

Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized Phase II, placebo-controlled trial

10.1080/21645515.2020.1861875

Saved in:
Bibliographic Details
Main Authors: Eujung Juliana Park, SOPHIA ARCHULETA, May-Lin Helen Oh, LYNETTE PEI-CHI SHEK, Hao Wang, Matthew Bonaparte, Carina Frago, Alain Bouckenooghe, Frederique Jantet-Blaudez, Sarah Begue, Sophie Gimenez-Fourage, Anke Pagnon
Other Authors: MEDICINE
Format: Article
Published: Taylor & Francis 2021
Online Access:https://scholarbank.nus.edu.sg/handle/10635/194505
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Description
Summary:10.1080/21645515.2020.1861875

Similar Items